Navigation Links
'Fecal Transplants' Show Promise for Gastrointestinal Ills
Date:11/1/2011

By Amanda Gardner
HealthDay Reporter

TUESDAY, Nov. 1 (HealthDay News) -- They sound disgusting, but doctors say "fecal transplants" -- once shunned by the medical establishment -- are proving useful against a range of gastrointestinal ailments, new research says.

Presenting at the American College of Gastroenterology annual meeting in Washington, D.C., researchers report that the therapy can ease severe irritable bowel syndrome and nasty bacterial infections.

Fecal microbiota transplant (FMT) involves taking feces from a donor, typically a spouse or relative though it could be anyone, after a light colonoscopy prep.

That sample is then mixed "with some saline so that it's a consistency that can be aspirated into 60 cc syringes," explained Dr. Mark Mellow, one of the researchers presenting findings at the meeting.

The patient then undergoes a routine colonoscopy during which the mixture is inserted. The idea is that this new, transplanted population of healthy flora will correct the patient's underlying problem and it does seem to work.

Some of the most encouraging research comes in the form of three studies which demonstrated the procedure's effectiveness against recalcitrant infection with the bacterium Clostridium difficile. The bug can cause disabling and even life-threatening diarrhea, nausea, vomiting and abdominal pain.

"Patients who have multiple C. difficile recurrences have a totally different population of bacteria that normal people do," said Mellow, who is medical director of the Digestive Health Center at Integris Baptist Medical Center in Oklahoma City. "The key thing is a marked decrease in diversity so, instead of having tons of different strains of microorganisms, they have many less strains and species than many people do."

In Mellow's study, 98 percent of patients with C. difficile who hadn't responded to a mean of five previous treatment courses saw rapid resolution of their symptoms -- if not with the first FMT transplant, then with a second.

The patients had been suffering for a mean of 11 months and many were ill enough to be in acute-care or skilled nursing facilities or homebound, Mellow said.

Dr. David Bernstein, chief of gastroenterology at North Shore University Hospital in Manhasset, N.Y., said: "It seems that this is potentially a phenomenal treatment for C. difficile infection, especially those that are refractory. This works and it's dramatic how quickly it works.

"C. difficile is becoming a greater problem in hospitals, and we're seeing more resistance and morbidity and mortality," he added.

Although it might seem difficult to find a volunteer, Bernstein felt that acceptance among patients would be high because "they've done so much already that has failed. They're desperate."

The transplants would not be first-line treatment for patients, however, Mellow said.

Researchers in Australia also reported success using FMT to treat ulcerative colitis and Crohn's disease in three patients. In all cases, symptoms improved within days or weeks.

Other studies being presented at the meeting found effectiveness with probiotics, live "friendly bacteria" similar to those found naturally in the gut. The idea is similar to an FMT transplant but probiotics are generally sold as dietary supplements or come in foods such as yogurt.

More information

The Mayo Clinic has more on Clostridium difficult.

SOURCES: Mark Mellow, M.D., medical director, Digestive Health Center, Integris Baptist Medical Center, Oklahoma City; David Bernstein, M.D., chief, gastroenterology, North Shore University Hospital, Manhasset, N.Y.; Oct. 31, 2011, presentations, American College of Gastroenterology annual meeting, Washington, D.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Noninvasive fecal occult blood test effective screen for lower GI tract lesions
2. 1 in 6 Cellphones in Britain Contaminated With Fecal Matter
3. Internal Anthem Blue Cross/WellPoint Document: Only Patients Who Push Back Get Covered Out of State Liver Transplants
4. Los Angeles Hair Transplant Cosmetic Surgeon Corrects Bad Hair Transplants With New Hair Restoration Method
5. Kidney transplants: Expanding the pool of available organs
6. Patients with treatment-resistant CLL respond positively to stem cell transplants
7. Hispanics and Asians less likely to receive liver transplants
8. Biosynthetic Corneas Show Promise in Transplants
9. OHSU research suggests compound administered during some bone marrow transplants elevates risks
10. Kidney Transplants for Elderly Double Over Decade
11. HIV Patients Do Well After Kidney Transplants: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Fecal Transplants' Show Promise for Gastrointestinal Ills
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the ... heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving ... Countless deodorants flood the aisles that contain harmful chemicals that should be put ...
(Date:4/27/2017)... ... , ... Goodcents Deli Fresh Subs announced a franchise expansion agreement today including ... , The first new location will open at the corner of 27th and Randolph ... Lights Drive this fall. And the third location is in the process of being ...
(Date:4/26/2017)... ... 2017 , ... Jump Technologies, Inc., an innovative software company ... a round of funding to accelerate its growth strategies. The $3.5 million investment ... a growth equity firm focused on investments in healthcare and technology companies. This ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
Breaking Medicine Technology: